Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.

MLA

Yu, Irene S., et al. “Medical Oncologists’ Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.” The Oncologist, vol. 25, no. 3, Mar. 2020, pp. 229–34. EBSCOhost, https://doi.org/10.1634/theoncologist.2019-0553.

APA

Yu, I. S., Pereira, A. A. L., Lee, M., Korphaisarn, K., Marshall, J., Segelov, E., O’Callaghan, C., Lim, H. J., Kopetz, S., & Loree, J. M. (2020). Medical Oncologists’ Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer. The Oncologist, 25(3), 229–234. https://doi.org/10.1634/theoncologist.2019-0553

Chicago

Yu, Irene S, Allan A L Pereira, Michael Lee, Kritti Korphaisarn, John Marshall, Eva Segelov, Chris O’Callaghan, Howard J Lim, Scott Kopetz, and Jonathan M Loree. 2020. “Medical Oncologists’ Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.” The Oncologist 25 (3): 229–34. doi:10.1634/theoncologist.2019-0553.